4DMedical (ASX:4DX) struck a three-year commercial deal with US medical imaging provider SimonMed Imaging covering the use of its advanced quantitative cardiopulmonary analysis technology, according to a Friday filing with the Australian bourse.

SimonMed will deploy 4DMedical's CT:VQ and LDAf technology to support clinical decision making for pulmonary assessment at pricing that is based on 4DMedical's per-scan rates, per the filing.

"While the agreement is not immediately financially material, the deployment with SimonMed represents a clear commercial win for 4DMedical, and a material long-term opportunity," the company said.

The deal with SimonMed, which operates more than 170 outpatient imaging centers in the US, represents CT:VQ's entry into the country's outpatient market.

4DMedical shares surged 11% in recent Friday trade.